Health Catalyst (HCAT) Cash & Equivalents (2018 - 2026)

Health Catalyst has reported Cash & Equivalents for 9 years, with the latest figure at $59.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 82.49% year-over-year to $59.9 million; the trailing twelve-month figure through Mar 2026 stood at $59.9 million (down 82.49% YoY), and the FY2025 full-year result was $50.8 million, down 79.65% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $59.9 million, up from $50.8 million in the prior quarter.
• The five-year high for Cash & Equivalents was $342.0 million in Q1 2025, with the low at $40.3 million in Q3 2025.
• Historically, Cash & Equivalents has averaged $152.4 million across 5 years, with a median of $124.2 million in 2022.
• Annual changes were most pronounced in 2024 — Cash & Equivalents soared 245.71% — and 2025, when it slumped 87.72%.
• Health Catalyst's Cash & Equivalents stood at $116.3 million in 2022, then retreated by 8.63% to $106.3 million in 2023, then soared by 134.9% to $249.6 million in 2024, then slumped by 79.65% to $50.8 million in 2025, then advanced by 17.81% to $59.9 million in 2026.
• The last three Cash & Equivalents figures came in at $59.9 million (Q1 2026), $50.8 million (Q4 2025), and $40.3 million (Q3 2025), per Business Quant data.